HomeXSPRAY • STO
add
XSpray Pharma AB (publ)
Previous close
kr 31.50
Day range
kr 30.90 - kr 31.85
Year range
kr 23.00 - kr 90.61
Market cap
1.15B SEK
Avg Volume
24.34K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 40.92M | -39.22% |
Net income | -42.29M | 37.57% |
Net profit margin | — | — |
Earnings per share | -1.14 | — |
EBITDA | -39.51M | 38.87% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 125.72M | 20.71% |
Total assets | 737.71M | 4.58% |
Total liabilities | 157.25M | 95.95% |
Total equity | 580.46M | — |
Shares outstanding | 37.14M | — |
Price to book | 2.02 | — |
Return on assets | -13.34% | — |
Return on capital | -14.03% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -42.29M | 37.57% |
Cash from operations | -66.33M | -19.92% |
Cash from investing | -14.70M | -185.51% |
Cash from financing | -1.39M | 23.74% |
Net change in cash | -82.51M | -32.77% |
Free cash flow | -66.12M | -94.81% |
About
Founded
2003
Website
Employees
26
